• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Co-opting Biological Processes to Drug Cancer and Other Diseases

Wednesday, June 05, 2024
Breakout Session
Oncology
26B
Co-opting of biological processes opened some of the most fruitful areas of drug discovery, from the wildly successful degraders that utilize the E3 ligase-proteasome pathway to Argenx's Vyvgart that uses FcRn-mediated IgG recycling to treat autoimmune diseases. In this session, panelists will discuss a new generation of approaches that cleverly exploit biological processes -- from novel intra- and extracellular degraders to sequence-specific inhibitors of protein synthesis to pH-engineered ADCs that recycle their targets back to cell surface for more payload pickup.
Moderator
Mariana Mihalusova, PhD
Investor
Venrock
Speakers
Larry Hamann, PhD
Co-founder/CEO
Interdict Bio
Aetna Wun Trombley, Ph.D.
CEO
Lycia
Bernd Boidol, PhD
CEO
Proxygen
Brian Fiske, PhD
Co-founder/CSO
Mythic Therapeutics
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS